TELA Bio, Inc. - 8-K Filing
TELA Bio reports Q3 2026 revenue of $19.0 million and implements a strategic cost reduction initiative to reduce annual operating expenses by $17.0 million. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $TELA